 Usefulness antithrombotic therapy angina pectoris non-Q-wave myocardial infarction death myocardial infarction pilot study Antithrombotic Therapy Acute Coronary Syndromes Study Group prospective pilot trial antithrombotic therapy acute coronary syndromes ATACS unstable angina pectoris non-Q-wave myocardial infarction different antithrombotic regimens prevention recurrent ischemic events efficacy Ninety-three patients aspirin mg/day full-dose heparin warfarin combination aspirin mg/day heparin Trial antithrombotic therapy standardized antianginal medication months end point Analysis intention-to-treat end points following recurrent ischemia patients aspirin patients heparin warfarin patients aspirin heparin warfarin coronary revascularization patients aspirin patients heparin warfarin patients aspirin heparin warfarin myocardial infarction patient aspirin patients heparin warfarin patient aspirin heparin deaths aspirin aspirin heparin patient warfarin major bleeding patients aspirin patients heparin warfarin patients aspirin heparin Recurrent myocardial ischemia days randomization